PATENT CLAIM ANALYSIS

Application Number: 16007046
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "006200"]

Abstract:
Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.

Claim (Index 74):
A compound selected from the group consisting of wherein the disulfide linkages between the Cys 6  and Cys 11  residues of the A-chain polypeptide and the disulfide linkages between the Cys 7  and Cys 20  of the A-chain to the Cys 7  and Cys 19  of the B-chain polypeptide, respectively, are represented by the solid line therebetween; wherein the linking moieties are covalently linked to the epsilon amino acid of the shown lysine residue, wherein the A-chain polypeptide for Dimers 71, 72, 77 and 78 has the amino acid sequence shown in SEQ ID NO:1; and the B-chain polypeptide for Dimers 71, 72, 77 and 78 has the amino acid sequence shown in SEQ ID NO:2 respectively.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14945461', '16301010', '14431040', '14504476', '15191584']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8372667280020265
- 35 USC 102 Novelty (BERT): 0.6652246119794998
- Combined Prediction Score: 0.8200625163997739
- Mean Citation Score: 447.387708
- Max Citation Score: 682.5196
- Similarity Product: 627.7613388756034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test